Where to buy Tesamorelin in the UK: the sellers with a verifiable COA
The newest verifiable Tesamorelin certificate on any UK seller's website is on Lab77Peptides (lab77peptides.uk), analysed 29 Sep 2026 (task #231376 on Janoshik's site); 12 verified sellers hold one covering Tesamorelin, listed newest first below.
Who holds the newest Tesamorelin report (12 verified UK sellers)
| Seller | Newest Tesamorelin report | Age of that report | |
|---|---|---|---|
| Lab77Peptides lab77peptides.uk | 29 Sep 2026 | 21 days | verify |
| Mercia Research merciaresearch.com | 17 Sep 2026 | 1 month, 3 days | verify |
| Peptology Labs peptologylabs.uk | 10 Sep 2026 | 1 month, 10 days | verify |
| BioVanta Research biovantaresearch.com | 25 May 2026 | 4 months, 25 days | verify |
| Phoenixbiolabs phoenixbiolabs.net | 19 May 2026 | 5 months, 1 day | verify |
| Thoroughbredlabs thoroughbredlabs.co.uk | 15 May 2026 | 5 months, 5 days | verify |
| Peptifyuk peptifyuk.com | 11 May 2026 | 5 months, 9 days | verify |
| Ascendpeptidesuk ascendpeptidesuk.com | 31 Mar 2026 | 6 months, 20 days | verify |
| Regenix Peptides regenix-peptides.co.uk | 17 Feb 2026 | 8 months, 3 days | verify |
| Clinicore clinicore.co.uk | 19 Jan 2026 | 9 months, 1 day | verify |
| Imperialpeptides imperialpeptides.co.uk | 15 Jan 2026 | 9 months, 5 days | verify |
| Xlpeptides xlpeptides.com | 28 Jan 2025 | 20 months, 22 days | verify |
Newest report first. Every report was opened on Janoshik's own website and names the seller as the client. The date is the analysis date printed on the report. The verify link opens the laboratory, never the shop. Audit findings, not recommendations.
A record of paperwork, not a recommendation: The Peptide Watch sells nothing, takes no money from sellers and links to none of them.
Why the date matters · What purity means · What Tesamorelin is · Regulators · Every report
Every Tesamorelin purity report we have read (13), one row per report
The 13 verifiable Tesamorelin certificates we have read, newest first
Each row was opened on Janoshik's own site by a real page load and transcribed. The client column is the name the laboratory printed; a certificate counts as a seller's own only when that name is the seller. The report date is the analysis date printed on the report where we have read it, otherwise the date the laboratory received the sample. The verify link opens the laboratory, never the shop. Audit findings, not recommendations.
| Seller | Task | Client on the report | Report date | Result | Batch | |
|---|---|---|---|---|---|---|
| Lab77Peptides | #231376 | Lab77peptides.uk | 29 Sep 2026 | Tesamorelin · 10.36 mg · 98.241% | L77tsm2612 | verify |
| Mercia Research | #231798 | Mercia Research Limited | 17 Sep 2026 | Tesamorelin · 7.05 mg/ml · 96.470% | MRL-26Q3-A05 | verify |
| Peptology Labs | #230188 | Peptology Labs | 10 Sep 2026 | Tesamorelin · 10.89 mg · 98.429% | TS4185 | verify |
| Lab77Peptides | #193652 | Lab77Peptides.co.uk | 19 Jun 2026 | Tesamorelin · 10.86 mg · 97.419% | 77TSM265 | verify |
| BioVanta Research | #153912 | Biovanta Research | 25 May 2026 | Tesamorelin · 5.12 mg · 96.078% | TSM-123QW | verify |
| Phoenixbiolabs | #147254 | www.phoenixbiolabs.net | 19 May 2026 | Tesamorelin · 4.96 mg · 98.110% | Batch-0143 used in vials + pen(s) | verify |
| Thoroughbredlabs | #149078 | Thoroughbred Labs | [email protected] | 15 May 2026 | Tesamorelin · 5.22 mg · 98.040% | TBLTE598 | verify |
| Peptifyuk | #149062 | Peptify UK | 11 May 2026 | Tesamorelin · 10.78 mg · 99.093% | 2026/04 | verify |
| Ascendpeptidesuk | #125394 | Ascend Peptides UK | 31 Mar 2026 | Tesamorelin · 10.74 mg · 99.501% | 20260114 | verify |
| Regenix Peptides | #103613 | https://regenix-peptides.co.uk | 17 Feb 2026 | Tesamorelin · 10.39 mg · 99.642% | TESA101 | verify |
| Clinicore | #100573 | clinicore | 19 Jan 2026 | Tesamorelin · 11.41 mg · 99.704% | te10101 | verify |
| Imperialpeptides | #99744 | Imperial Peptides UK | www.imperialpeptides.co.uk | 15 Jan 2026 | Tesamorelin · 8.03 mg · 99.559% | TES5-01/28 | verify |
| Xlpeptides | #56758 | XL Peptides | 28 Jan 2025 | Tesamorelin · 6.27 mg · 99.276% | 007001 | verify |
Why the date on a certificate matters
What a purity figure means
The purity on a Janoshik report is the share of the main peak in an HPLC chromatogram. 99.5% means that 99.5% of what the detector saw was one substance and 0.5% was something else. It is not the amount in the vial: that is the separate quantity line, in milligrams. It does not by itself prove which substance the peak is: that is identity, confirmed by mass spectrometry. And it says nothing about sterility, endotoxins or heavy metals, which are separate tests.
A purity figure printed on a shop page with no report behind it is a claim, not a measurement. Between two reports, the difference that matters is rarely 99.2% against 99.8%; it is whether the report exists at all, names the seller as the client, covers this compound on its own, and is recent.
What Tesamorelin is, and what it is sold as
Tesamorelin is a synthetic analogue of growth-hormone-releasing hormone (GHRH) studied in metabolic research. Because the cheaper, shorter GHRH-family peptides sermorelin and CJC-1295 are common relabelling targets, an identity test (mass spectrometry) confirming the actual compound matters as much as the purity figure.
| Development status | Approved in the US only. FDA-approved for HIV-associated lipodystrophy since 2010; the European application was withdrawn in 2012. |
|---|---|
| Originator | Theratechnologies (TH9507). Rights: Theratechnologies; marketed as Egrifta and Egrifta WR. |
| Registered clinical trials | 24 on ClinicalTrials.gov |
An approved medicine in the United States, for one narrow use. Tesamorelin is Theratechnologies' Egrifta, approved by the FDA in November 2010 to reduce excess abdominal fat in adults with HIV-associated lipodystrophy, with a weekly formulation approved in 2025. PubMed indexes 104 papers, 24 of them clinical-trial reports; ClinicalTrials.gov lists 24 registered trials.
Not in Europe. Theratechnologies withdrew its European application on 22 June 2012, citing the lack of long-term safety data on raised IGF-1 and the absence of a cardiovascular endpoint. It has never been licensed in the UK or EU.
The evidence is for the licensed product in that population. Nothing in the trial record supports use in healthy adults, and none of it says what is in a research-chemical vial; only a verifiable certificate does that.
The published record in numbers, and the sources
| Papers on PubMed | 104 |
|---|---|
| Indexed as rat or mouse studies | 3 |
| Indexed as clinical trials | 24 |
| Published since 2020 | 36 |
Counts are from PubMed on 15 September 2026 using the queries recorded in our evidence file. A description of the published record, not medical advice and not an argument for or against use.
- Effects of Tesamorelin on Neurocognitive Impairment in Persons With HIV and Abdominal Obesity. (J Infect Dis, 2025, PMID 39813152)
- Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors. (AIDS, 2024, PMID 38905488)
- Growth Hormone Releasing Hormone Reduces Circulating Markers of Immune Activation in Parallel with Effects on Hepatic Immune Pathways in Individuals with HIV-infection and Nonalcoholic Fatty Liver Disease. (Clin Infect Dis, 2021, PMID 33852720)
- Clinical Predictors of Liver Fibrosis Presence and Progression in Human Immunodeficiency Virus-Associated Nonalcoholic Fatty Liver Disease. (Clin Infect Dis, 2021, PMID 32270862)
- Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians. (Am J Sports Med, 2026, PMID 41476424)
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. (J Am Acad Orthop Surg Glob Res Rev, 2026, PMID 41490200)
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. (Sports Med, 2026, PMID 41966639)
- HIV i-Base, FDA approves tesamorelin (2010)
- HIV i-Base, Theratechnologies withdraws EU application (2012)
- Drugs.com, Egrifta WR approval history
What regulators say about Tesamorelin
In the UK. Not licensed in the UK or EU. Sold as a research chemical.
We hold no statement from the FDA, MHRA or EMA specifically about Tesamorelin on file. Its development and licence sources are listed under the record above.
What the 13 Tesamorelin certificates show
We have read 13 Janoshik reports covering Tesamorelin, published by 12 UK sellers. Each was opened on Janoshik's own website. All 13 name the seller itself as the client. 8 of the 13 are dated within the last six months and 1 is more than a year old. The newest is dated 29 Sep 2026 and the oldest 28 Jan 2025.
All 13 reports give a purity figure for Tesamorelin. The figures run from 96.078% to 99.704%, and 6 of the 13 are at 99% or above. A purity figure describes the sample the laboratory received, not every vial from that batch.
Read directly from the newest reports: Lab77Peptides: task #231376, analysed 29 Sep 2026, 10.36 mg recovered at 98.241%, client Lab77peptides.uk; Mercia Research: task #231798, analysed 17 Sep 2026, 7.05 mg/ml at 96.470%, client Mercia Research Limited; Peptology Labs: task #230188, analysed 10 Sep 2026, 10.89 mg recovered at 98.429%, client Peptology Labs.
A certificate is a batch document. The lines that matter are the compound (it must say Tesamorelin, not only a batch code), the client (the shop, not its supplier) and the analysis date. A new batch is untested until a new report appears.
Tesamorelin in the UK at a glance
| Active UK sellers listing Tesamorelin | 54 |
|---|---|
| Of which publish a verifiable own-name certificate | 13 |
| Of which name no laboratory at all | 13 |
Counted from the vendor ledger at build time. The A-Z directory lists every seller and what each publishes instead.
Questions people ask
Which UK sellers publish a verifiable Janoshik certificate naming Tesamorelin?
As of 20 October 2026, 12: Lab77Peptides, Mercia Research, Peptology Labs, BioVanta Research, Phoenixbiolabs, Thoroughbredlabs, Peptifyuk, Ascendpeptidesuk, Regenix Peptides, Clinicore, Imperialpeptides, Xlpeptides. Each has a report on Janoshik's own website that names the seller as the client and lists Tesamorelin. That is a statement about paperwork, not a recommendation; The Peptide Watch does not recommend anywhere to buy Tesamorelin.
How recent is the newest Tesamorelin certificate from a UK seller?
The newest we have read is Janoshik task #231376, analysed 29 Sep 2026. It is published by Lab77Peptides and names it as the client. A certificate covers one batch, so an old one says little about stock on sale today.
How do I check that a certificate for Tesamorelin is genuine?
Four things: an independent laboratory is named; the client field names the seller you are buying from, not a supplier; the compound line says Tesamorelin; and the report's task number and key open the same report on the laboratory's own website (verify.janoshik.com). A branded PDF with no laboratory name and no verification code fails on the first check, however professional it looks. The free COA Checker on this site runs the checks for you.
Is Tesamorelin a licensed medicine in the UK?
Not licensed in the UK or EU. Sold as a research chemical. FDA-approved for HIV-associated lipodystrophy since 2010; the European application was withdrawn in 2012. The Peptide Watch does not give legal or medical advice.
Why does The Peptide Watch not say where to buy Tesamorelin?
Because the site records paperwork, not recommendations. A verifiable certificate proves that a sample of one batch was tested. It does not prove the vial you receive matches it, and it says nothing about whether anyone should use Tesamorelin. Listing which sellers publish a certificate you can check, and which publish nothing, is as far as the evidence goes.
The Peptide Watch's position on Tesamorelin
Not licensed in the UK or EU. Sold as a research chemical. The Peptide Watch reads the certificates UK sellers publish and does not recommend anywhere to buy Tesamorelin. Sellers on this page are listed by the date of their newest Tesamorelin certificate and by nothing else. If you can verify a seller's testing, you can at least judge its evidence; if you cannot, you are taking the seller's word for what is in the vial. See how UK testing compares across every seller in the market statistics.
An honest note: a verifiable certificate proves a sample of a batch was tested, not that the specific vial you receive matches it, see what this can and can't tell you. The Peptide Watch sells no Tesamorelin and links to no shop; this is research-use-only information, not medical or dosing advice.
All peptides · Other compounds: BPC-157 · TB-500 · GHK-Cu · Ipamorelin · CJC-1295 · MOTS-c · Epithalon · Selank · Semax · Melanotan 2 · KPV · PT-141 · SS-31 · DSIP · NAD+ · Melanotan 1 · AOD-9604 · 5-Amino-1MQ · Glutathione · Kisspeptin · Thymosin Alpha-1 · GHRP-6 · HGH Fragment 176-191 · IGF-1 LR3 · FOXO4-DRI · Oxytocin · SLU-PP-332 · MK-677 · GLOW and KLOW blends · Sermorelin · GHRP-2 · Hexarelin · ARA-290 · AHK-Cu